Reinjury of arterial lesions induces intimal smooth muscle cell replication that is not controlled by fibroblast growth factor 2

被引:42
作者
Koyama, H [1 ]
Reidy, MA [1 ]
机构
[1] UNIV WASHINGTON, DEPT PATHOL, SEATTLE, WA 98195 USA
关键词
angioplasty; fibroblast growth factor; smooth muscle cell replication;
D O I
10.1161/01.res.0000435857.23307.bd
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this study we have examined the response of rat carotid arteries with intimal lesions to an angioplasty injury. Rat carotid arteries were subjected to injury with a 2F Fogarty catheter (first injury), and 28 days later the same arteries were subjected to reinjury with a 1.5-mm-diameter coronary dilation catheter (second injury) or a sham operation. After the second injury, the injured arterial surfaces were covered by a platelet monolayer, with occasional small thrombi. The size of the intimal area was significantly increased 28 days after the second injury, although the luminal area was not changed at this time. Intimal and medial cell replication, measured by 5-bromo-2'-deoxyuridine labeling, was significantly increased at 2 days after the second injury but was markedly reduced by 7 days. Addition of fibroblast growth factor-2 (FGF2, 60 mu g IV) did not increase smooth muscle cell (SMC) replication in arteries subjected to the second injury, and replication was not inhibited with an antibody against FGF2 (120 mg IV). Both these reagents, however, did significantly affect SMC replication in normal carotid arteries subjected to Fogarty catheter injury. In a similar manner, heparin (888 UPS units/kg body wt IV) did not inhibit cell replication after second injury, although it did suppress SMC replication after a single injury. One conclusion is that rat intimal cells in vivo are different from medial SMCs and that other, as-yet-unknown, factors are important for their proliferation.
引用
收藏
页码:408 / 417
页数:10
相关论文
共 36 条
[1]   INTIMAL PROLIFERATION OF SMOOTH-MUSCLE CELLS AS AN EXPLANATION FOR RECURRENT CORONARY-ARTERY STENOSIS AFTER PERCUTANEOUS TRANS-LUMINAL CORONARY ANGIOPLASTY [J].
AUSTIN, GE ;
RATLIFF, NB ;
HOLLMAN, J ;
TABEI, S ;
PHILLIPS, DF .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1985, 6 (02) :369-375
[2]  
BALCON R, 1992, CIRCULATION, V86, P100
[3]   MORPHOLOGY AFTER TRANS-LUMINAL ANGIOPLASTY IN HUMAN-BEINGS [J].
BLOCK, PC ;
MYLER, RK ;
STERTZER, S ;
FALLON, JT .
NEW ENGLAND JOURNAL OF MEDICINE, 1981, 305 (07) :382-385
[4]  
BOWENPOPE DF, 1982, J BIOL CHEM, V257, P5161
[5]  
CLOWES AW, 1983, LAB INVEST, V49, P327
[6]  
CLOWES AW, 1983, LAB INVEST, V49, P208
[7]  
CLOWES AW, 1986, LAB INVEST, V54, P295
[8]   RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY - HAVE WE BEEN AIMING AT THE WRONG TARGET [J].
CURRIER, JW ;
FAXON, DP .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1995, 25 (02) :516-520
[9]  
DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589
[10]   LONG-TERM EFFECTS OF ANGIOPEPTIN TREATMENT IN CORONARY ANGIOPLASTY - REDUCTION OF CLINICAL EVENTS BUT NOT ANGIOGRAPHIC RESTENOSIS [J].
EMANUELSSON, H ;
BEATT, KJ ;
BAGGER, JP ;
BALCON, R ;
HEIKKILA, J ;
PIESSENS, J ;
SCHAEFFER, M ;
SURYAPRANATA, H ;
FOEGH, M .
CIRCULATION, 1995, 91 (06) :1689-1696